Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Fuji
Baxter
Federal Trade Commission
Citi
Deloitte
Argus Health
Harvard Business School

Generated: December 14, 2018

DrugPatentWatch Database Preview

Litigation Details for WARNER-LAMBERT COMPA v. PUREPAC PHARMACEUTIC (D.N.J. )

« Back to Dashboard

Small Molecule Drugs cited in WARNER-LAMBERT COMPA v. PUREPAC PHARMACEUTIC
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for WARNER-LAMBERT COMPA v. PUREPAC PHARMACEUTIC (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2011-05-12 1154 listing of Patent Nos. 4,894,476 (the ‘476 Patent)24 and 5,084,479 (the ‘479 Patent)25 in the Orange…infringement of U.S. Patent No. 6,054,482, entitled “Lactam- Free Amino Acids” (the “‘482 Patent”). The ‘482…procurement of the particular patent in question.” In re Gabapentin Patent Litig., MDL No. 00- 2931 … Plaintiffs argue that the ‘482 Patent is a composition patent and thus is valid for all potential… PageID: 39172 A patent holder, upon a finding that a patent is valid and infringed, is entitled External link to document
2009-08-27 683 obtained U.S. Patent No. 4,894,476 (the “‘476 Patent”) claiming the new monohydrate. The ‘476 Patent expired…resulting patent prosecution. The low-lactam gabapentin patent ultimately issued as the ‘482 Patent on April…the patent, to use the patent as a tool to restrain trade in areas not claimed under the patent, the…subsequent IDS to cite an additional patent, Patent No. 4,228,179 (the “‘179 Patent”) which was also directed…for issuance as U.S. Patent No. 5,395,852 (the “‘852 Patent”). The ‘852 Patent was scheduled to issue External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Covington
Merck
Fish and Richardson
Argus Health
Deloitte
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.